cilostazol has been researched along with Sepsis in 2 studies
Sepsis: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Whether cilostazol (6-[4-(1-cyclohexyl-1H-tetrazol-5-yl) butoxy]-3,4-dihydro-2-(1H)-quinolinone), anticoagulant, protects mice against sepsis and underlying mechanism(s) were investigated." | 3.81 | Cilostazol inhibits HMGB1 release in LPS-activated RAW 264.7 cells and increases the survival of septic mice. ( Chang, KC, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nomura, K | 1 |
| Miyashita, T | 1 |
| Yamamoto, Y | 1 |
| Munesue, S | 1 |
| Harashima, A | 1 |
| Takayama, H | 1 |
| Fushida, S | 1 |
| Ohta, T | 1 |
| Chang, KC | 1 |
2 other studies available for cilostazol and Sepsis
| Article | Year |
|---|---|
Citrullinated Histone H3: Early Biomarker of Neutrophil Extracellular Traps in Septic Liver Damage.
Topics: Animals; Biomarkers; Cilostazol; Citrullination; Extracellular Traps; Histones; Lipopolysaccharides; | 2019 |
Cilostazol inhibits HMGB1 release in LPS-activated RAW 264.7 cells and increases the survival of septic mice.
Topics: Animals; Anticoagulants; Cilostazol; Dose-Response Relationship, Drug; Heme Oxygenase-1; HMGB1 Prote | 2015 |